YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Successful Treatment of Nephrotic Syndrome Due To Fmf Amyloidosis With Azathioprine: Report of Three Turkish Cases

dc.authorid Reha, Erkoc/0009-0001-7230-8843
dc.authorid Sayarlioglu, Mehmet/0000-0001-6214-1974
dc.authorscopusid 55911844200
dc.authorscopusid 8409430500
dc.authorscopusid 6602520064
dc.authorscopusid 23666715400
dc.authorscopusid 13105952900
dc.contributor.author Sayarlioglu, Hayriye
dc.contributor.author Erkoc, Reba
dc.contributor.author Sayarliogin, Mehmet
dc.contributor.author Dogan, Ekrem
dc.contributor.author Soyoral, Yasemin
dc.date.accessioned 2025-05-10T17:07:27Z
dc.date.available 2025-05-10T17:07:27Z
dc.date.issued 2006
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Sutcu Imam Univ, Fac Med, Dept Internal Med, Div Nephrol, TR-46050 Kahramanmaras, Turkey; Yuzuncu Yil Univ, Fac Med, Div Nephrol, Dept Internal Med, Van, Turkey en_US
dc.description Reha, Erkoc/0009-0001-7230-8843; Sayarlioglu, Mehmet/0000-0001-6214-1974 en_US
dc.description.abstract Secondary amyloidosis is a well-known complication of certain familial Mediterranean fever (FMF). We presented three Turkish patients with FMF and biopsy proven amyloidosis. These patients were treated with colchicine 1.5 mg/day. They have experienced five to six peritonitis attacks with fever within 1 year. On admission, the laboratory test results were as follows: serum creatinine 2.3, 0.6, and 0.5 mg/dl; albumin 4.2, 1.9, and 1.8 g/dl; and urinary protein excretion 4, 15, and 10 g/day, respectively. All the patients were started azathioprine (AZA) 100 mg/day and attacks were completely stopped. Laboratory findings were as follows after I year of AZA treatment: serum creatinine 1, 0.8, and 0.6 mg/dl; albumin 4.3, 3, and 3.5 g/dl; and urinary protein excretion 3, 8, and 1.5 g/day, respectively. Treatment with azathioprine in addition to colchicine could ameliorate the nephrotic syndrome and control the attacks very effectively in these cases. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1007/s00296-006-0188-2
dc.identifier.endpage 199 en_US
dc.identifier.issn 0172-8172
dc.identifier.issn 1437-160X
dc.identifier.issue 2 en_US
dc.identifier.pmid 16944160
dc.identifier.scopus 2-s2.0-33846114183
dc.identifier.scopusquality Q2
dc.identifier.startpage 197 en_US
dc.identifier.uri https://doi.org/10.1007/s00296-006-0188-2
dc.identifier.uri https://hdl.handle.net/20.500.14720/6776
dc.identifier.volume 27 en_US
dc.identifier.wos WOS:000243226400015
dc.identifier.wosquality Q2
dc.language.iso en en_US
dc.publisher Springer Heidelberg en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Fmf en_US
dc.subject Secondary Amyloidosis en_US
dc.subject Azathioprine en_US
dc.title Successful Treatment of Nephrotic Syndrome Due To Fmf Amyloidosis With Azathioprine: Report of Three Turkish Cases en_US
dc.type Article en_US

Files